Association of Helicobacter pylori infection with the correa cascade: a single-center, retrospective cohort study
Zhangsen Huang1,2, Liang Gu1,2, Yuntao Shi1,2
1Digestive Medicine Center, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.
Insights
Helicobacter pylori infection is linked to worsening gastric conditions, including precancerous lesions. Eradicating H. pylori is crucial for preventing disease progression and managing gastric health.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Oncology
Background:
- Helicobacter pylori (H. pylori) is a key cause of gastric diseases.
- Limited data exists on H. pylori prevalence across the full spectrum of gastric histopathology in a Chinese cohort.
Purpose of the Study:
- To investigate H. pylori infection prevalence across Correa cascade stages.
- To analyze H. pylori's influence on histopathological progression in a longitudinal Chinese cohort.
Main Methods:
- Retrospective analysis of 13,579 participants undergoing gastroscopy and 14C-Urea Breath Test (UBT).
- Assessment of gastric mucosa via endoscopic and histopathological findings.
- Longitudinal analysis using Cox regression to determine disease progression risk.
Main Results:
- Overall H. pylori prevalence was 62.54%, significantly associated with Correa cascade stages.
- Prevalence was highest in low-grade intraepithelial neoplasia (77.46%) and lowest in non-atrophic gastritis (61.05%).
- H. pylori-positive individuals showed higher disease progression rates (9.67% vs. 5.60%) and increased risk (adjusted HR=1.60).
Conclusions:
- H. pylori infection is significantly associated with advanced gastric lesions and disease progression.
- Eradication of H. pylori is vital for halting gastric disease advancement.
Background:
Helicobacter pylori (H. pylori) is a primary etiological agent for various gastric pathologies. Although numerous studies have described the association between H. pylori and individual stages of the Correa cascade, data comprehensively evaluating its prevalence across the full histopathological spectrum-from non-atrophic gastritis (NAG) to gastric cancer (GC)-within a single Chinese cohort remain limited. This study aimed to investigate the association between H. pylori infection and specific endoscopic stages, and further analyzed its influence on histopathological progression in a longitudinal sub-cohort.
Methods:
A retrospective study was conducted using data from participants who underwent concurrent gastroscopy and a 14C-Urea breath test (UBT) at the endoscopy center at Fengqing people's Hospital between January 2019 and December 2024. Gastric mucosa status was assessed based on endoscopic and histopathological biopsy findings. Statistical associations were evaluated using the chi-square test. Correlations were analyzed using Spearman coefficients. A longitudinal sub-cohort was analyzed to compare disease progression between baseline H. pylori-positive and -negative groups. The hazard ratio (HR) and 95% confidence interval (CI) for incident disease progression were calculated by Cox proportional hazards regression.
Results:
A total of 13,579 participants were included, and the overall prevalence of H. pylori infection was 62.54%. A statistically significant association was found between H. pylori infection and gastric sequential stages of Correa's cascade. The infection rate varied across pathological groups, being highest in participants with low-grade intraepithelial neoplasia (LGIN) (77.46%), and lowest in those with non-atrophic gastritis (NAG) (61.05%). In the longitudinal sub-cohort, the disease progression rate was higher among participants who were H. pylori-positive at baseline compared to their negative counterparts (9.67% vs. 5.60%, p = 0.0043). The HR for disease progression was significantly increased among H. pylori-positive participants compared with H. pylori-negative participants after sex- and age-adjustment [adjusted HR = 1.60 (1.07-2.39), p=0.021].
Conclusion:
Our study reveals a significant association between H. pylori infection and advanced gastric lesions, and confirms its significant impact on disease progression. This evidence solidifies the importance of eradication in clinical management to halt disease advancement.
Related Concept Videos
Gastritis II: Pathophysiology
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Peptic Ulcer Disease II: Pathophysiology
